Opening Recap
Market Pulse: Retail momentum rippled through Wall Street as discount darling Ross Stores notched its strongest week ever and Opendoor shares jumped over 16% after a surprising earnings beat, all while AI chatter left tech names treading water.
Key Movers: Ross Stores reclaimed center stage with its inventory clearance and raised guidance (Ross Stores Stock Had Its Best Week Ever. Here's Why.), and Opendoor stunned skeptics with a rally on sustained home-flip volumes (What’s behind Opendoor’s impressive 16% stock rally). Meanwhile, Michael Burry’s bold short against Nvidia stirred up chatter.
Macro & Politics: The rupee slipped past the 89 mark after the RBI paused interventions, underscoring emerging-market strains (No anchor, rupee sinks to 89/Dollar).
What’s Next: Eyes turn to Fed speakers and the upcoming CPI print before Monday’s opening bell.
Market Commentary
Everyone’s so fixated on Ross Stores’ inventory surge (Ross Stores Stock Had Its Best Week Ever. Here's Why., Barchart.com) and Opendoor’s 16% leap (What’s behind Opendoor’s impressive 16% stock rally, Rolling Out), but nobody’s talking about how a slipping rupee (No anchor, rupee sinks to 89/Dollar, The Times of India) could rip emerging-market portfolios apart if India’s central bank stays sidelined. That’s a silent dagger in the financial back, and most traders haven’t noticed yet.
You’d think biotech’s routine FDA update (Sangamo Therapeutics Announces FDA Acceptance of BLA Rolling Submission Request for ST-920 in Fabry Disease, GlobeNewswire) and Michael Burry’s crusade against AI giants (The internet is loving ‘Big Short' investor Michael Burry’s crusade against Nvidia and the AI giants, Business Insider) have nothing in common, but both underline a growing distrust in hype-driven narratives. When a famed short-seller calls bullshit on NVDA and regulators fast-track gene therapy applications, you know the herd is chasing yesterday’s story.
Action time: if you’re itching to deploy capital, consider covered calls on areas facing bubble chatter—think Nvidia (With Earnings Behind It, Nvidia Stock Looks Ripe for Covered Calls, Barchart.com)—while scouting biotech catalysts like Sangamo’s ST-920 BLA rolling submission (GlobeNewswire) for asymmetric upside. Mix a pinch of skepticism with bold positioning—that’s where profits usually hide.
📈 Breaking Financial News
Ross Stores Stock Had Its Best Week Ever. Here's Why.
Ross Stores surged to an all-time high with a major Q3 earnings beat, soaring foot traffic, and raised guidance, while tech stocks crashed around it.
Here Are Friday’s Top Wall Street Analysts Research Calls: Advanced Micro Devices, Block, Broadcom, Exact Sciences, Hologic, Palo Alto Networks and More
Quick Read
The stock market saw a massive reversal on Thursday after an impressive morning rally sparked by NVIDIA’s big earnings beat.
Stronger-than-expected September job numbers fueled worries that the Federal Reserve will not lower rates in Decem…
Pulsetto Black Friday Sale: Vagus Nerve Stimulation Devices for Stress Relief Now Available at Promotional Pricing
Lithuanian-Made Cervical VNS Technology Reaches 100,000+ Users Worldwide as FCC-Certified Wellness Devices Gain Traction for Non-Pharmaceutical Stress Management and Sleep Support Lithuanian-Made Cervical VNS Technology Reaches 100,000+ Users Worldwide as FCC…
Crypto Company Creates Bizarre Drug
A bizarre cryptocurrency company is creating an alternative to the widely used opium reversal drug Naxalone, for inexplicable reasons.
The internet is loving ‘Big Short' investor Michael Burry's crusade against Nvidia and the AI giants
Michael Burry of “The Big Short” is lighting up social media after betting against Nvidia and Palantir and casting doubt on the AI boom.
Top Secret Facility in the New Mexico Desert…
Inside, scientists aren't studying weapons or viruses—they're exploring a far more alien technology that could change how wars are fought. This new technology could be unleashed as soon as October 14th. Once you see it for yourself, you'll understand the urgency.
🔍 Market Analysis & Insights
Nvidia CEO says the company is in a no-win situation amid AI-bubble chatter, leaked meeting reveals
With Earnings Behind It, Nvidia Stock Looks Ripe for Covered Calls
With the post-earnings rush behind it and price action flattening out, Nvidia may settle into a quieter, more predictable range. That backdrop is built for…
AquaSculpt Ice Hack Explained: Why Plant-Based Metabolic Support Supplements Are Replacing High-Caffeine Fat Burners—L-Carnitine, Berberine & Chromium Multi-Pathway Approach Addresses FDA Registration Confusion and Safety Concerns
Cold Thermogenesis Combined With Multi-Ingredient Supplementation Creates New Category as Industry Addresses Widespread Consumer Confusion About FDA Regulation, Third-Party Testing Standards, and Ingredient Transparency in Ice Water Weight Loss Market Cold Th…
What’s behind Opendoor’s impressive 16% stock rally
Opendoor Technologies is capturing serious attention from Wall Street after delivering a performance that sent shares soaring more than 16% and left investors buzzing about the company’s transformation. The real estate technology firm closed at $7.63 per shar…
No anchor, rupee sinks to 89/Dollar
In a dramatic trading session on Friday, the Indian Rupee fell to its lowest level ever against the US Dollar, breaching the 89 mark. This unexpected decline unfolded in the closing hour, with traders highlighting several issues: insufficient intervention fro…
Congress to feature Trump on $100 Bill?
A shocking new plan was just introduced in Washington. The idea is to celebrate Trump's new “golden age” by placing him on the $100 bill. As you'll see, it has little to do with the new Crypto Reserve… Or Trump's ambitious plan for Artificial Intelligence… Former Presidential Advisor, Jim Rickards says, “Trump's crowning achievement will be much, much bigger.” In the months ahead, he predicts, the government will release a massive multi-trillion-dollar asset which it has held back for more than a century. And this will give ordinary investors a chance to strike it rich.
💰 Investment Opportunities
Rupee weakens past the 89/$1 level for the first time as RBI stops intervening
The Indian Rupee reached an all-time low against the US Dollar on Friday. It crossed the significant 89 per dollar mark for the first time. Traders cited a lack of Reserve Bank of India intervention and a high trade deficit as key reasons. The currency experi…
Cardiac Arrhythmia Monitoring Devices Market Size Worth USD 15.01 Bn by 2034
According to Precedence Research, the global cardiac arrhythmia monitoring devices market size will grow from USD 8.40 billion in 2025 to nearly USD 15.01 billion by 2034, with an expected CAGR of 6.67% from 2025 to 2034. According to Precedence Research, the…
Hip Replacement Market Poised to Reach US$ 11.4 Billion by 2033 | Astute Analytica
Hip replacement market is advancing confidently, propelled by an aging population seeking active lifestyles and groundbreaking surgical technologies. A pivotal shift toward outpatient procedures is reshaping care delivery, increasing efficiency while demand f…
Sangamo Therapeutics Announces FDA Acceptance of BLA Rolling Submission Request for ST-920 in Fabry Disease
U.S. FDA has accepted Sangamo’s request for a rolling submission and review of the BLA for ST-920 in Fabry disease……
60 Degrees Pharmaceuticals Announces Clinical Site Now Open for Patient Enrollment for the B-FREE Chronic Babesiosis Study at Mount Sinai Icahn School of Medicine
60 Degrees Pharma opens enrollment at Mount Sinai for its B-FREE trial testing tafenoquine in chronic babesiosis, addressing a major unmet medical need.
“This man is my kind of contrarian” Renowned Futurist, Eric Fry, has been seen o
“Nvidia, Amazon and Tesla are ticking time bombs in investors' portfolios,” he says. Instead, he's sharing three NEW stocks positioned to take over as the tech kingpins of tomorrow. Get Eric's full “Sell This, Buy That” list right here.